TLR4 and coronary atherosclerosis: Plasma EV-lnc-MRGPRF-6:1 upregulation promotes macrophage M1 polarization and inflammation in coronary atherosclerosis patients by activating toll-like receptor-4, myeloid differentiation factor-88, and mitogen-activated protein kinases (TLR4-MyD88-MAPK) [41].